Pulmotree Medical GmbH is a German medical technology company specializing in inhalation-based drug delivery for respiratory and systemic therapies. It develops patient-centric inhalation devices—such as smart nebulizers—and connected digital solutions that support therapy monitoring and adherence.
The company collaborates with pharmaceutical and biotech partners on drug–device combination products, providing capabilities from concept development and human‑factors engineering to prototyping, verification and small‑series manufacturing, with pathways to scale-up. Its work spans indications such as asthma, COPD, and other pulmonary diseases, as well as targeted pulmonary delivery for specialty medicines.
Pulmotree operates at the interface of medtech and pharmaceutical development, focusing on improving the efficiency, reliability, and usability of inhalation therapies.
None yet. When a new project in the record names Pulmotree as owner, partner or investor, it shows here.
Adds Kolibri NPLI platform to support complex inhaled therapies including biologics, and integrates formulation, device, regulatory and digital services for end‑to‑end development.
